Petra Prins

645 citations
25 papers · 251 indexed · h-index 9
Topics
Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Cancer Immunotherapy and Biomarkers (4 papers)Pancreatic and Hepatic Oncology Research (4 papers)

In The Last Decade

Petra Prins

24 papers receiving 250 citations

Peers

Petra Prins
Comparison fields: 5 of 56
  • Oncology 76
  • Molecular Biology 65
  • Cellular and Molecular Neuroscience 53
  • Cancer Research 49
  • Pulmonary and Respiratory Medicine 45
Replace Michael Yourshaw with:
Michael Yourshaw United States
Mélanie Guyot France
Nobuyoshi Kittaka Japan
Sylvana Tahraoui France
Johannes C. Melms United States
Hong-Bo Huan China
J. Wang China
Y. Venel France
Weihong Kuang China
Petra Prins relative to Michael Yourshaw United States Michael Yourshaw's profile →
Citations per field
00.5×1.5×2.2×
Michael Yourshaw · 1×
Citations per year

Countries citing papers authored by Petra Prins

Since Specialization
Citations

This map shows the geographic impact of Petra Prins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Prins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Prins more than expected).

Fields of papers citing papers by Petra Prins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Prins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Prins. The network helps show where Petra Prins may publish in the future.

Co-authorship network of co-authors of Petra Prins

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Prins. A scholar is included among the top collaborators of Petra Prins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Prins. Petra Prins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 2
3 2
4 2
5 9
6 2
7 54
8 19
9 1
10 2
11 1
12 0
13 5
14 13
15 1
16 17
17 19
18 8
19 66
20 10

About Petra Prins

Petra Prins is a scholar working on Hepatology, Biotechnology and Cancer Research, having authored 25 papers that have together received 251 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Hepatology (45 citations), Cancer Research (49 citations) and Cellular and Molecular Neuroscience (53 citations). Petra Prins has collaborated with scholars based in United States, France and Puerto Rico. Frequent co-authors include Aiwu Ruth He, Sebastian Ochoa, Marion L. Hartley, Jarod Swant, Brittany Butler, John L. Marshall, Habibeh Khoshbouei, Joyonna Gamble‐George, John T. Clark and Rebecca Heltsley. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026